Clover Health Investments ROA 2020-2025 | CLOV
Current and historical return on assets (ROA) values for Clover Health Investments (CLOV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Clover Health Investments ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.06B | $0.56B | -10.09% |
| 2025-06-30 | $-0.04B | $0.58B | -7.19% |
| 2025-03-31 | $-0.03B | $0.58B | -4.01% |
| 2024-12-31 | $-0.04B | $0.58B | -6.67% |
| 2024-09-30 | $-0.09B | $0.65B | -14.16% |
| 2024-06-30 | $-0.12B | $0.67B | -16.53% |
| 2024-03-31 | $-0.16B | $0.67B | -17.86% |
| 2023-12-31 | $-0.21B | $0.57B | -19.62% |
| 2023-09-30 | $-0.23B | $1.06B | -19.82% |
| 2023-06-30 | $-0.26B | $1.26B | -20.56% |
| 2023-03-31 | $-0.34B | $1.45B | -22.84% |
| 2022-12-31 | $-0.34B | $0.81B | -19.02% |
| 2022-09-30 | $-0.44B | $1.56B | -24.32% |
| 2022-06-30 | $-0.40B | $2.06B | -24.13% |
| 2022-03-31 | $-0.62B | $2.68B | -42.42% |
| 2021-12-31 | $-0.59B | $0.95B | -59.01% |
| 2021-09-30 | $-0.53B | $0.95B | -63.84% |
| 2021-06-30 | $-0.48B | $1.22B | -60.27% |
| 2021-03-31 | $-0.16B | $0.87B | -22.35% |
| 2020-12-31 | $-0.14B | $0.27B | -28.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.338B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.353B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |